Click Here to return To Results

 

Safety and Tolerability of Gene Therapy With an Adeno-Associated Virus (AAV) Borne GAD gene for Parkinsons Disease: An Open Label, Phase I Trial Lancet 369:2097-2105,2056, Kaplitt,M.G.,et al, 2007 See this aricle in Pubmed Article Abstract AAV-GAD gene therapy of the subthalamic nucleus is safe and well tolerated by patients with advanced Parkinsons disease, suggesting that in-vivo gene therapy in the adult brain might be safe for various neurodegenerative diseases.

Related Tags

(click to filter results - removes previous filter) advances in neurology degenerative diseases of CNS gene therapy glutamic acid decarboxylase Parkinson disease Parkinson disease,surgical treatment of Parkinson disease,treatment of safety subthalamic nucleus treatment of neurologic disorder viral infection

Click Here to return To Results